Business Wire

Align Clinical CRO: Leading CROs Form New Industry Standards Group to Improve Collaboration with Sponsors

Jaa

Six leading contract research organizations (CROs) and Veeva Systems (NYSE:VEEV) today introduced Align Clinical CRO, a new industry standards group dedicated to making it easier for sponsors and CROs to work together during clinical trials. Founding members, with input across the industry, plan to help create open technology standards intended to improve trial execution and collaboration with life sciences companies.

For the first time, leading CROs, including ICON plc, Medpace, Pharmaceutical Product Development, LLC (PPD), PRA Health Sciences, Syneos Health, and UBC are coming together to develop open technology standards to transform clinical trial operations across the entire industry to speed product development.

“There is tremendous potential to enhance clinical trial execution with common technology standards that benefit the entire industry,” said Henry Levy, president of Align Clinical CRO. “The assembly of Align Clinical CRO represents an important industry collaboration to improve the trial process and how the industry works together to accelerate drug development.”

Align Clinical CRO will create open technology standards intended to help increase sponsor and CRO productivity, reduce operational costs, and run trials faster. The group’s first standard is anticipated to be an Operational Data Exchange standard to facilitate seamless information sharing between sponsors and CROs. This is expected to include the definition of a technical standard for data to be exchanged between a sponsor and a CRO relating to the operational execution of a trial, including key metrics and milestone information.

CROs play an integral role in supporting drug development, with clinical outsourcing expected to increase to 50% by 2020.1 As sponsors run a growing number of trials with multiple CROs, developing pre-competitive industry standards will help bring more consistency to trial management and address the complexity of trial oversight to make drug development processes more efficient.

Align Clinical CRO will post its Operational Data Exchange standard for public review and input later this year, which will also be reviewed and considered as part of the adoption of proposed standards. Visit AlignClinicalCRO.org to learn about the group’s mission and stay up-to-date on the standards in development.

What Align Clinical CRO Members Are Saying:
“Leading experts are coming together in Align Clinical CRO to streamline how data is shared between CROs and sponsors during trials,” said Thomas O’Leary, chief information officer at ICON plc. “We look forward to contributing to the group and creating standards that drive greater speed and productivity across the industry.”

“Align Clinical CRO will play an important role in helping the industry accelerate innovation and get new treatments to patients faster,” said Mark Roseman, senior vice president of clinical operations at Medpace. “We are excited to join forces with like-minded CROs that want to move the industry forward and make clinical trial execution more efficient.”

“This is the first time CROs are coming together to make this commitment to transform clinical trials across our industry and we are excited to be part of this effort,” said Michael Brooks, executive vice president of product registration at PRA Health Sciences. “This shows our mutual commitment to make the drug development process more efficient and to help bring needed therapies to market more quickly.”

“Align Clinical CRO will help speed the timeline for gaining new therapy approvals for patients,” said Rachel Stahler, chief information officer at Syneos Health. “By creating a vehicle for CROs to collaborate and share actionable insight with sponsors, we can improve operational delivery and streamline the increasingly complex trial process.”

“UBC is excited to join Align Clinical CRO,” said Brett Huselton, senior vice president of commercial strategy for product and opportunity development at UBC. “We are committed to developing open technology standards that benefit the entire industry and make clinical trial processes more efficient.”

Additional Information
Connect with Align Clinical CRO on Linkedin: linkedin.com/company/align-clinical-cro
Follow @AlignCRO on Twitter: twitter.com/AlignCRO

About Align Clinical CRO
Align Clinical CRO is an industry standards group founded by Veeva Systems and the world’s largest CROs, including ICON plc, Medpace, Pharmaceutical Product Development LLC (PPD), PRA Health Sciences, Syneos Health, and UBC. The group is dedicated to creating open technology standards that improve trial execution and collaboration with life sciences companies, making it easier for sponsors and CROs to work together during clinical trials. For more information, visit www.alignclinicalcro.org.

###

______________________________________
1 CRO Industry Primer: A 2016 Credit Suisse Research Analysis, June 2016

Contact information

Veeva Systems Inc.
Sue Glanville / Cate Bonthuys
sue@catalystcomms.co.uk / cate@catalystcomms.co.uk
+44 (0) 7715 817589 / +44 (0) 7746 546773

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

CORRECTING and REPLACING FlexTrade Launches FlexNOW Execution Management System (EMS)23.4.2018 11:56Tiedote

Quote in sixth paragraph should be attributed to Lucas Howarth, Fund Manager at Wesleyan (sted of Chris Beton, CTO/CRO at Everett Capital Advisors). The corrected release reads: FLEXTRADE LAUNCHES FLEXNOW EXECUTION MANAGEMENT SYSTEM (EMS) – One-Click Deployment System for Hedge Funds and Mini-Primes – – MiFID II Compliant Trading for Equities, Futures & Options – FlexTrade (@FlexTrade) today announced the official release of FlexNOW, an out-of-the-box, broker neutral EMS to address the needs of hedge funds and mini-primes who require a streamlined, multi-asset trading system at the click of a button. Multi-Asset, MiFID II Compliant Trading -- Designed to handle trading for equities, futures and options, FlexNOW is MiFID II compliant; provides connectivity to leading market data providers; easily integrates with any order management system (OMS) via FIX and API; and comes with its own built-in transaction cost analysis functionality. Easy Installation -- According to Rhyd Lewis, FlexNOW

FlexTrade Launches FlexNOW Execution Management System (EMS)23.4.2018 11:00Tiedote

FlexTrade (@FlexTrade) today announced the official release of FlexNOW, an out-of-the-box, broker neutral EMS to address the needs of hedge funds and mini-primes who require a streamlined, multi-asset trading system at the click of a button. Multi-Asset, MiFID II Compliant Trading -- Designed to handle trading for equities, futures and options, FlexNOW is MiFID II compliant; provides connectivity to leading market data providers; easily integrates with any order management system (OMS) via FIX and API; and comes with its own built-in transaction cost analysis functionality. Easy Installation -- According to Rhyd Lewis, FlexNOW Product Manager at FlexTrade UK, FlexNOW’s zero-touch onboarding and installation process gets clients up and running in a matter of minutes. “By combining the one-click installation process with secure, online connectivity, we have greatly reduced the on-boarding lead time for customers,” said Lewis. Streamlined Trading Workflows -- “We developed FlexNOW based o

Limited Edition Skechers D’Lites & Toei Animation One Piece Collection to Launch in Europe23.4.2018 10:00Tiedote

After initially launching in Asia and with an upcoming debut in the United States and Canada, SKECHERS USA, Inc. (NYSE:SKX) is extending its popular anime collaboration to Europe as well with the launch of Skechers X One Piece. The colorful collection unites Toei Animation’s popular anime series with Skechers D’Lites, one of the footwear company’s original styles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180423005239/en/ Skechers launches limited edition One Piece collection in Europe (Photo: Business Wire) “Pairing the iconic long-running anime series One Piece with one of our top heritage styles resonated with our consumers in South Korea and China who have been driving trends for the past few years,” began Michael Greenberg, president of Skechers. “And now fashion moves at light speed, so as influencers around the world had already been embracing Skechers D’Lites and the chunky sneaker trend, we started to see style

Enapter Showcases its Anion Exchange Membrane (AEM) Electrolyser at HANNOVER MESSE 2018.23.4.2018 09:00Tiedote

With new investors and management, the former ACTA/Heliocentris Italy changed the name to Enapter, and is showcasing innovations to the existing product line. Enapter offers electrolyser systems in the range of 250L to 1000L/h. Enapter stacks are small, flexible, modular. The electrolysers are scalable and enable cost effective systems of up to 48kW. They produce clean and dry hydrogen, directly compressed to 35 bar. The electrolyser can be powered from any source. Enapter is also demonstrating existing international use-cases where on-site hydrogen production is realized; such as back-up power for off-grid houses, telecom towers, production and laboratory use. At the Hannover Fair, Enapter continues to showcase its Anion Exchange Membrane (AEM) Technology. AEM operates in a non-corrosive, slightly alkaline environment, where no noble metals are required to achieve a good lifetime. This unique technology combines the benefits of cost-efficient alkaline electrolysis with those of the Pr

China’s Bakery Industry @ Bakery China 2018 (May 9-12, Shanghai)23.4.2018 09:00Tiedote

With an exhibition area of over 200,000 square meters this year, Bakery China 2018, to be held on May 9-12, has attracted more than 2,100 exhibitors from all over the world. As an important indicator of China’s robust growth on bakery, Bakery China (www.bakerychina.com) was launched 21 years ago and has developed into the world’s largest exhibition in this area. As the organisers of this high-profile and impactful event, China Association of Bakery & Confectionery Industry (CABCI) and Bakery China Exhibitions Co., Ltd. will welcome more than 140,000 professional visitors from over 110 countries and regions at the Shanghai New International Expo Center for Bakery China 2018, where every participant will truly experience the vibrant prosperity and innovation of China’s bakery industry. China’s bakery industry, which has been experiencing a rapid growth since the end of last century, boasted a 20% average growth rate between 2003 and 2016 and is emerging as a global leader in the industry

Armance Bordes Joins Sofinnova Partners as General Counsel23.4.2018 09:00Tiedote

Sofinnova Partners, a leading European venture capital firm specialized in Life Sciences, has appointed Armance Bordes as General Counsel. In charge of the firm’s legal and regulatory affairs, Armance brings to Sofinnova Partners a ten-year experience in private equity. Prior to joining Sofinnova Partners, Armance was Deputy General Counsel and Secretary of the board of directors at Eurazeo. She has supervised numerous investments and divestments in listed companies; she has been involved in particular in the IPOs of Elis and Europcar in which she has been a board member. Armance started her career as an M&A lawyer at Gibson Dunn & Crutcher, LLP in Paris. She graduated from the University of Paris I Panthéon -Sorbonne and holds a postgraduate diploma from Oxford University. She is admitted to the Paris bar. As part of a growing support team headed by Monique Saulnier, Managing Partner & COO of Sofinnova Partners, Armance will work in close ties with Christophe Blanche, Chief Financial

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme